[Discussion on diagnosis and treatment of hepatobiliary malignancies during the outbreak of COVID-19]
- PMID: 32108460
- DOI: 10.3760/cma.j.cn112152-20200227-00137
[Discussion on diagnosis and treatment of hepatobiliary malignancies during the outbreak of COVID-19]
Abstract
Objective: From December 2019, the new coronavirus pneumonia (COVID-19) broke out in Wuhan, Hubei, and spread rapidly to the nationwide. On January 20, 2020, the National Health Committee classified COVID-19 pneumonia as one of B class infectious diseases and treated it as class A infectious disease. During the epidemic period, the routine diagnosis and treatment of tumor patients was affected with varying degrees. In this special period, we performed the superiority of the multi-disciplinary team of diagnosis and treatment, achieved accurate diagnosis and treatment of patients with hepatobiliary malignant tumors, provided support for these patients with limited medical resources, and helped them to survive during the epidemic period.On the basis of fully understanding the new coronavirus pneumonia, the treatment strategy should be changed timely during the epidemic, and more appropriate treatment methods should be adopted to minimize the adverse effect of the epidemic on tumor treatment.
2019年12月底新型冠状病毒肺炎(COVID－19)在湖北武汉暴发，短时间内疫情蔓延至全国范围。2020年1月20日，国家卫生健康委员会将COVID－19纳入乙类传染病并按照甲类传染病进行防治。在抗击疫情期间，肿瘤患者的常规诊治流程受到了不同程度的影响。在这一特殊时期，应充分发挥多学科诊疗团队的优势，做到肝胆系统恶性肿瘤患者的精准诊疗，利用有限的医疗资源为患者提供支持，帮助患者度过疫情。在充分认识COVID－19的基础上，疫情期间适时转变治疗策略，采用更加适宜时局的治疗方式，最大程度降低疫情对肿瘤治疗造成的影响。.
Keywords: COVID-19; Diagnosis and treatment; Hepatobiliary system; Neoplasms.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
